All lobbying filings

RK Strategies, Inc.

RK Strategies, Inc. filed a Q3 report for Neurothera Labs, Inc. on October 20, 2026, reporting $10,000 in lobbying income.

Lobbying for Neurothera Labs, Inc. · Pharmaceutical company

As filed: RK STRATEGIES, INC. for NEUROTHERA LABS, INC.

All filings by RK Strategies, Inc. · Everything Neurothera Labs, Inc. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$10,000

What the client paid this registrant for the period.

Client based in

Ontario

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

FDA Issues involving Orphan Drug Designation

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem